Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|November 3, 2025
Immune dysregulation and endothelial dysfunction associate with a pro-thrombotic profile in Long COVIDAlicia Simón-Rueda, Clara Sánchez-Menéndez, Guiomar Casado, et al.
Biochemical Pharmacology|August 25, 2018
Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitorsMercedes Bermejo, Juan Ambrosioni, Guiomar Bautista, et al.
Journal of Medical Virology|November 8, 2025
Changes in HIV-1 Reservoir Dynamics After Mpox InfectionGuiomar Casado-Fernández, Olivia de la Calle-Jiménez, Inés Armenteros, et al.
Frontiers in Immunology|October 6, 2025
Correction: Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysisClara Sánchez-Menéndez, Alejandro Zurdo, Magdalena Corona, et al.
Plos One|August 12, 2022
Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian cohortLorena Vigón, Miguel Galán, Montserrat Torres, et al.
Biochemical Pharmacology|August 24, 2020
Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infectionLorena Vigón, Sara Rodríguez-Mora, Alejandro Luna, et al.
Frontiers in Immunology|June 23, 2025
Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysisClara Sánchez-Menéndez, Alejandro Zurdo, Magdalena Corona, et al.
Cancers|May 16, 2023
Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after VaccinationSara Rodríguez-Mora, Lucía Pérez-Lamas, Miriam Solera Sainero, et al.
Frontiers in Immunology|June 14, 2021
Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease SeverityLorena Vigón, Daniel Fuertes, Javier García-Pérez, et al.
Frontiers in Immunology|October 7, 2021
Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICULorena Vigón, Javier García-Pérez, Sara Rodríguez-Mora, et al.
Pageof 8